Xilio Therapeutics, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2020 | — | $-54.6M | $-55.2M |
| FY2021 | — | $-75.0M | $-75.8M |
| FY2022 | — | $-89.1M | $-88.2M |
| FY2023 | — | $-79.1M | $-76.4M |
| FY2024 | $6.3M | $-60.6M | $-58.2M |
| FY2025 | $43.8M | $-42.0M | $-35.0M |
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2020 | — | $-54.6M | $-55.2M |
| FY2021 | — | $-75.0M | $-75.8M |
| FY2022 | — | $-89.1M | $-88.2M |
| FY2023 | — | $-79.1M | $-76.4M |
| FY2024 | $6.3M | $-60.6M | $-58.2M |
| FY2025 | $43.8M | $-42.0M | $-35.0M |